Smartleaf Asset Management’s Arcus Biosciences RCUS Stock Holding History

Smartleaf Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.78K	Hold	186	–	–	﹤0.01%	2629
2026 Q1	$3.84K	Sell	186 -108	-37%	-$2.33K	﹤0.01%	2772
2025 Q4	$6.83K	Buy	294 +293	+29,300%	+$5.98K	﹤0.01%	2566
2025 Q3	$13	Buy	+1	New	+$10	﹤0.01%	2997
2024 Q4	–	Sell	-21	Closed	-$323	–	2999
2024 Q3	$323	Buy	21 +8	+62%	+$126	﹤0.01%	2837
2024 Q2	$197	Buy	+13	New	+$210	﹤0.01%	2677

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Smartleaf Asset Management's RCUS Position: Q2 2026 in Review

Smartleaf Asset Management held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 186 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2629.

Smartleaf Asset Management first reported a position in RCUS in Q2 2024 and has held it in 6 quarters since. The position peaked at $6.83K in Q4 2025. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Smartleaf Asset Management held 186 shares of Arcus Biosciences worth $5.78K as of Q2 2026.
Smartleaf Asset Management left its Arcus Biosciences share count unchanged in Q2 2026.
Arcus Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2629 holding.
Smartleaf Asset Management first reported a position in Arcus Biosciences in Q2 2024 and has held it in 6 quarters since.
Smartleaf Asset Management's Arcus Biosciences position peaked at $6.83K in Q4 2025.
231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.